Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
Recruiting now · Phase 2 · Has a placebo group
Conditions studied: Acute Gouty Arthritis, Gout Flare, Gout Flares, Acute Gout Flare
In brief
A randomized, double-blind, international multicenter, colchicine and placebo-controlled study to evaluate the efficacy and safety of ABP-745 in subjects with acute gout. Efficacy of ABP-745 in reducing pain and swelling compared with standard colchicine treatment and placebo will be evaluated in participants with acute gout. The primary efficacy measurement will be pain score after treatment.
Key facts
- Study ID
- NCT07145229
- Run by
- Atom Therapeutics Co., Ltd
- People needed
- 380
- Starts
- 2025-08-26
- Expected to finish
- 2026-06-01
- Last updated by the study team
- 2025-12-08
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Wenzhou People's Hospital — Wenzhou, Zhejiang, China (enrolling)
- Exinia Research — La Mesa, California, United States (enrolling)
- Chengdu Fifth People's Hospital — Chengdu, Sichuan, China (enrolling)
- Hangzhou First People's Hospital — Hangzhou, Zhejiang, China (enrolling)
- Onyx Clinical Research — Peoria, Arizona, United States (enrolling)
- Bioluminux Clinical Research — Naperville, Illinois, United States (enrolling)
- Exinia Research — Des Moines, Iowa, United States (enrolling)
- Northshore Research Associates — Alexandria, Louisiana, United States (enrolling)
- DelRicht Research — Baton Rouge, Louisiana, United States (enrolling)
- DelRicht Research — New Orleans, Louisiana, United States (enrolling)
- Interphase Clinical Trials — Lutherville, Maryland, United States (enrolling)
- DelRicht Research Gulfport — Gulfport, Mississippi, United States (enrolling)
- Albuquerque Clinical Trials, Inc. — Albuquerque, New Mexico, United States (enrolling)
- DelRicht Research — Tulsa, Oklahoma, United States (enrolling)
- Emeritus Sydney — Botany, New South Wales, Australia (enrolling)
- Canopy Clinical Research Northern Beaches — Brookvale, New South Wales, Australia (enrolling)
- Novatrials — Kotara, New South Wales, Australia (enrolling)
- Genesis Research Services — Newcastle, New South Wales, Australia (enrolling)
- Emeritus Melbourne — Camberwell, Victoria, Australia (enrolling)
- Canopy Clinical Research Altona North — North Altona, Victoria, Australia (enrolling)
- Peking University Third hospital — Beijing, Beijing Municipality, China (enrolling)
- Xuanwu Hospital Capital Medical University — Beijing, Beijing Municipality, China (enrolling)
- The second affiliated hospital of guangxi medical university — Nanning, Guangxi, China (enrolling)
- Hebei Petro China Central Hospital — Langfang, Hebei, China (enrolling)
- Wuhan UHospital, Tongji Medical College, Huazhong University of Science and Technology — Wuhan, Hubei, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.